New white paper from MASA® exposes hidden workplace risk: The high cost of hesitation in medical emergencies
SUNRISE, Fla., Oct. 28, 2025 /PRNewswire/ — A new white paper from MASA® reveals an often-overlooked but escalating crisis that threatens American... Read more.
Identity Theft Resource Center 2025 Consumer Impact Report: Financial & Emotional Impacts Rise Across the Board; AI is Seen as a Threat
Losses that total between $10,000 to more than $1 million are now common, helping to drive high levels of emotional distress, including thoughts of self-harm SAN... Read more.
ATI Announces Third Quarter 2025 Results
Continued year-over-year sales growth driven by aerospace & defense Record aerospace & defense sales of $793 million, representing 70% of Q 3 2025 sales... Read more.
Myrio Therapeutics Announces Collaboration with Leading Research Institutions to Advance Solid Tumor T cell Immunotherapeutics
Myrio Therapeutics, the University of Pennsylvania Perelman School of Medicine, and NYU Langone Health have entered a research collaboration to accelerate the development... Read more.
BTQ Technologies Added to SamsungActive KoAct Global Quantum Computing Active ETF
Inclusion in Samsung Asset Management’s actively managed quantum computing ETF increases BTQ’s visibility with Asia-based institutional and thematic... Read more.
Syantra, Inc. Expands Reach and Impact to New Zealand through New Partnership with Breast Cancer Foundation NZ
CALGARY, AB, Oct. 28, 2025 /PRNewswire/ – Syantra, Inc., a precision biotechnology company revolutionizing early cancer detection, today announced a clinical... Read more.
HONEYWELL INTRODUCES NEW, INNOVATIVE TECHNOLOGY THAT PRODUCES LOW-COST, HIGH QUALITY RENEWABLE FUELS FROM BIOMASS
CHARLOTTE, N.C., Oct. 28, 2025 /PRNewswire/ — Honeywell (NASDAQ: HON) today introduced a breakthrough technology that converts agricultural and forestry... Read more.
Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care
Pelareorep plus atezolizumab achieves 30% ORR in second-line or later (≥2L) squamous cell anal carcinoma (SCAC) relative to 13.8% for the FDA-approved 2L... Read more.
Barclays to Acquire Leading U.S. Personal Loan Originator Best Egg
WILMINGTON, Del., Oct. 28, 2025 /PRNewswire/ — Barclays PLC (“Barclays”)1 today announces that its wholly-owned US consumer banking subsidiary... Read more.
Solver Announces New Integration with Microsoft Fabric
Empowering finance teams to transform data into actionable insights across the enterprise with Solver FP&A for Microsoft Fabric data LOS ANGELES, Oct. 28, 2025... Read more.